申请人:THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
公开号:US20220306575A1
公开(公告)日:2022-09-29
The present disclosure relates to a compound of formula (I)
where R
1
is as defined herein. The compound of formula I is an inhibitor of the dephosphorylation of phosphorylated elF2α. The phosphorylation of elF2α affects the quiescence and self renewal properties of stem cells such as muscle stem cells. The compound of formula (I) can thus be used to expand stem cells populations and treat degenerative diseases that have a quiescence regulation affected or mediated by the phosphorylation of elF2α.
本公开涉及一种式(I)的化合物,其中R1如本文所定义。式I的化合物是磷酸化elF2α去磷酸化的抑制剂。elF2α的磷酸化会影响干细胞(如肌肉干细胞)的静止和自我更新特性。因此,式(I)的化合物可用于扩大干细胞群体并治疗由elF2α磷酸化调节或介导的静止调节受影响的退行性疾病。